National Institutes of Health points to consider in the design and submission of human somatic-cell gene therapy protocols

dc.creator	National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee	en
dc.date.accessioned	2011-07-12T18:38:49Z	en
dc.date.available	2011-07-12T18:38:49Z	en
dc.date.created	1986-12	en
dc.date.issued	1986-12	en
dc.identifier.bibliographicCitation	Recombinant DNA Technical Bulletin 1986 December; 9(4): 221-242	en
dc.identifier.uri	http://hdl.handle.net/10822/540374	en
dc.format	Article	en
dc.language	eng	en
dc.source	69295	en
dc.subject	Gene Therapy	en
dc.subject	Health	en
dc.subject.classification	Gene Therapy / Gene Transfer	en
dc.subject.classification	Human Experimentation Policy Guidelines / Institutional Review Boards	en
dc.subject.classification	Social Control of Human Experimentation	en
dc.title	National Institutes of Health points to consider in the design and submission of human somatic-cell gene therapy protocols	en
dc.provenance	Digital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Institute	en
dc.provenance	Digital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown University	en

Related items